![]() ![]() | ||||||||||
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
||||
|
![]() |
![]() |
![]() |
Shigella flexneri Serotype 3 Infections Among Men Who Have Sex with Men --- Chicago, Illinois, 2003--2004During 2003--2004, the Chicago Department of Public Health (CDPH) investigated an increase in reported Shigella flexneri serotype 3 infections among adult males. This report summarizes the investigation into those cases and underscores the potential for sexual transmission of enteric infections among men who have sex with men (MSM). Shigellosis is a reportable disease in Illinois. During 1995--2002, a total of 95 cases of S. flexneri serotype 3 infection in Chicago residents were reported to CDPH (mean: 11.9 cases per year); 40 (42%) of these cases occurred in males aged >18 years (Figure 1). In contrast, 33 (85%) of 39 reported cases (mean: 19.5 cases per year) occurred in adult males during 2003--2004. The mean annual number of case reports among adult males increased from 5.0 to 16.5, whereas case reports among women and children decreased from 6.9 to 3.0 during this period. CDPH conducted an investigation to characterize these infections. For this investigation, a case of S. flexneri serotype 3 infection was defined as one with onset of diarrhea during 2003--2004 in a male Chicago resident aged >18 years, with accompanying isolation of S. flexneri serotype 3 from stool culture. Health-care providers were asked to report all Shigella infections among Chicago residents to CDPH and to send Shigella isolates to the state public health laboratory for speciation. Persons whose illness was consistent with the case definition were interviewed with a standard case-investigation questionnaire, which included the following questions: "With regard to sexual orientation, would you describe yourself as 1) heterosexual, 2) homosexual, 3) bisexual, 4) don't know, or 5) refused?" and "In the week prior to the onset of this illness, do you remember engaging in a same-sex relationship?" Responses were "yes", "no", or "don't know." Information about sexual activities and human immunodeficiency virus (HIV) status was not collected systematically. Serotyping, antimicrobial-susceptibility testing, and pulsed-field gel electrophoresis (PFGE) of available isolates were performed at the Illinois Department of Public Health and CDC. Illness onsets for 33 identified patients occurred throughout both years (Figure 2). In all patients, clinical illness was limited to gastroenteritis; 16 (48%) patients were hospitalized for treatment, and all recovered without sequelae. Patients ranged in age from 20 to 56 years (median: 35 years); 24 (83%) of 29 patients for whom race was ascertained were non-Hispanic white. Twenty-two (88%) of 25 patients asked to characterize their sexual orientation described themselves as MSM. No other common food, water, daycare, or travel exposures or risk factors for shigellosis were found. Fourteen isolates obtained from MSM were available for additional testing. Twelve (86%) were identified as S. flexneri subtype 3a; the remaining two isolates were S. flexneri subtype 3b. Seven closely related PFGE patterns were identified among the 11 S. flexneri subtype 3a isolates subtyped by PFGE. Eleven isolates were tested for antimicrobial susceptibility; all were susceptible to ciprofloxacin and resistant to ampicillin, and nine (82%) were resistant to trimethoprim-sulfamethoxazole. Reported by: JT Watson, MD, RC Jones, MPH, J Fernandez MC, C Cortes, SI Gerber, MD, Chicago Dept of Public Health; KJ Kuo, MS, JS Price, MS, Div of Laboratories, Illinois Dept of Public Health. JT Brooks, MD, Div of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention; D Jennings, M Fair, E Mintz, MD, Div of Bacterial and Mycotic Diseases, National Center for Infectious Diseases; A Bowen, MD, EIS Officer, CDC. Editorial Note:Shigella is the third most common cause of bacterial gastroenteritis in the United States (1). The majority of Shigella infections in the United States are caused by S. sonnei and affect young children and their caretakers. S. flexneri causes approximately 18% of U.S. Shigella infections (1). The national incidence of S. flexneri infections decreased 64% from 1989 to 2002 (1). However, a recent analysis indicated an increase in Shigella infection among adult males (2). This increase is likely attributable to outbreaks of shigellosis among MSM; since the 1970s, outbreaks of shigellosis attributable to S. flexneri and more recently S. sonnei have been reported among MSM in major cities in North America (3--5), Europe (6), and Australia (7). The low inoculum required for Shigella infection (as few as 10--200 organisms) facilitates person-to-person transmission. Risk factors for sexual transmission of Shigella have not been well characterized but likely involve exposure to fecal material. In outbreaks among MSM, 50%--90% of participants reported oral-genital or oral-anal contact during the week before diagnosis with Shigella infection (3,5). A case-control study of shigellosis among MSM in Sydney, Australia, implicated exposure to a commercial sex venue as the sole risk factor for illness (7). Although the effect of HIV infection on risk for sexual transmission of Shigella is not well understood, it might be associated with elevated risk for acquiring shigellosis and with more severe disease (8). Other enteric illnesses, such as those caused by hepatitis A, Entamoeba histolytica, Giardia lamblia, Campylobacter, and Salmonella, also can be transmitted sexually (4,9,10). Because feces can contain multiple pathogens, polymicrobial infections can result from a single sexual exposure (3,4). Outbreaks of sexually transmitted shigellosis might be observed more frequently than outbreaks of other sexually transmissible enteric organisms because the infectious dose is lower, the illness produces symptoms that are more likely to bring patients to medical attention, and laboratory diagnosis is simpler. More routine molecular subtyping of Shigella by PFGE might also facilitate recognition of epidemiologically related shigellosis clusters. To reduce the risk for sexually transmitted enteric infections, persons with diarrhea should refrain from oral-anal, oral-genital, and anal-genital contact while they are symptomatic. Because Shigella and other enteric pathogens can be carried asymptomatically, persons who engage in sexual contact that could expose them or their sex partners to fecal material should wash their hands and anal-genital regions thoroughly with soap and water before and after sexual activity. The use of condoms during oral-genital or anal-genital contact, dental dams during oral-anal contact, and gloves during digital-anal contact will help reduce the opportunities for sexual transmission of Shigella and other pathogens. Clinicians should request appropriate laboratory examinations, including stool culture for patients with diarrhea who are MSM, and counsel patients about the risk for infection with enteric pathogens during sexual activity that could expose them to feces. Shigella isolates should be routinely serotyped and molecularly subtyped by PFGE to assist in detection of outbreaks. Investigations of shigellosis outbreaks and outbreaks of other enteric diseases among MSM are needed to better characterize specific high-risk behaviors for transmission, identify effective prevention measures, and clarify the role of HIV infection and antiretroviral therapy in the sexual transmission of Shigella. References
|
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services. |
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Date last reviewed: 8/24/2005
![]() |
|||||
HOME |
ABOUT MMWR |
MMWR SEARCH |
DOWNLOADS |
RSS
|
CONTACT
|
|||||
![]() |
|||||
|